Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Kita

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Neurologic Clinics|March 29, 2011
FDA-approved preventative therapies for MS: first-line agentsMariko Kita
The Journal of Obstetrics and Gynaecology Research|February 13, 2010
Free peritoneal cyst with histologic properties of amniotic epithelium observed in a woman pregnant with twinsTsuguhiro Horikoshi, Akihiko Kikuchi, Kyoko Ono, et al.
Journal of Clinical Ultrasound : JCU|December 17, 2009
Prenatal ultrasound and magnetic resonance imaging depiction of a small sublingual ranulaShunsuke Tamaru, Akihiko Kikuchi, Kyoko Ono, et al.
Fetal Diagnosis and Therapy|June 10, 2009
Umbilical cord cysts of allantoic and omphalomesenteric remnants with progressive umbilical cord edema: a case reportMariko Kita, Akihiko Kikuchi, Susumu Miyashita, et al.
Congenital Anomalies|February 27, 2009
Prenatal diagnosis of Holt-Oram syndrome: role of 3-D ultrasonographySorahiro Sunagawa, Akihiko Kikuchi, Yoko Sano, et al.
Prenatal Diagnosis|June 21, 2008
Nonimmunologic hydropic fetalis associated with polypoid embolizations of both umbilical arteriesSorahiro Sunagawa, Akihiko Kikuchi, Kyoko Ono, et al.
Science Translational Medicine|February 1, 2013
In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signalingAnya Schneider, Sarah Alice Long, Karen Cerosaletti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosisRafael Arroyo González, Mariko Kita, Heidi Crayton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Mitoxantrone as a potential therapy for primary progressive multiple sclerosisOlaf Stüve, Mariko Kita, Daniel Pelletier, et al.
Biochemical and Biophysical Research Communications|May 2, 2008
PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestineJun Inoue, Shin-Ichi Satoh, Mariko Kita, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Neurologic Clinics|March 29, 2011
FDA-approved preventative therapies for MS: first-line agentsMariko Kita
The Journal of Obstetrics and Gynaecology Research|February 13, 2010
Free peritoneal cyst with histologic properties of amniotic epithelium observed in a woman pregnant with twinsTsuguhiro Horikoshi, Akihiko Kikuchi, Kyoko Ono, et al.
Journal of Clinical Ultrasound : JCU|December 17, 2009
Prenatal ultrasound and magnetic resonance imaging depiction of a small sublingual ranulaShunsuke Tamaru, Akihiko Kikuchi, Kyoko Ono, et al.
Fetal Diagnosis and Therapy|June 10, 2009
Umbilical cord cysts of allantoic and omphalomesenteric remnants with progressive umbilical cord edema: a case reportMariko Kita, Akihiko Kikuchi, Susumu Miyashita, et al.
Congenital Anomalies|February 27, 2009
Prenatal diagnosis of Holt-Oram syndrome: role of 3-D ultrasonographySorahiro Sunagawa, Akihiko Kikuchi, Yoko Sano, et al.
Prenatal Diagnosis|June 21, 2008
Nonimmunologic hydropic fetalis associated with polypoid embolizations of both umbilical arteriesSorahiro Sunagawa, Akihiko Kikuchi, Kyoko Ono, et al.
Science Translational Medicine|February 1, 2013
In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signalingAnya Schneider, Sarah Alice Long, Karen Cerosaletti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosisRafael Arroyo González, Mariko Kita, Heidi Crayton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2004
Mitoxantrone as a potential therapy for primary progressive multiple sclerosisOlaf Stüve, Mariko Kita, Daniel Pelletier, et al.
Biochemical and Biophysical Research Communications|May 2, 2008
PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestineJun Inoue, Shin-Ichi Satoh, Mariko Kita, et al.
Pageof 3